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Introduction
Asymptomatic oropharyngeal carriage of the Gram negative 
diplococcus Neisseria meningitidis occurs at a variable rate, 
with mean prevalence of around 10%, dependent on age and 
exposure to risk factors1. Humans are the sole known reser-
voir for the meningococcus, and as such it is an obligate human 
commensal and pathogen. Transmission of meningococci occurs 
by droplet spread through close contact with an infected indi-
vidual. Of those who carry meningococci, a very small number, 
1–2 per 100,000 in the UK2, will develop invasive meningo-
coccal disease (IMD) with the bacteria invading systemically 
through the oropharyngeal epithelium, resulting in septicaemia 
and/or meningitis.
A meta-analysis of meningococcal carriage in Europe, North 
America and Australia, where serogroups B and C IMD pre-
dominates, demonstrated increasing carriage with age from 
4.5% in infants to 23.7% in 19 year olds, subsequently declin-
ing in adulthood to 7.8% in 50 year olds3. Risk factors that 
affect carriage include; living in overcrowded settings; passive 
and active smoking; intimate contact (e.g. kissing); frequenting 
pubs or clubs; and intercurrent viral respiratory tract infection4–6. 
Carriage rates are dynamic and have been observed to rise in 
UK students starting university, from 6.9% on the first day of 
university term to 23.1% by day four7. Carriage rates as high as 
60–70% have been reported amongst military personnel, with 
disease outbreaks a common occurrence in both these settings8,9. 
There is variation in meningococcal carriage and disease epi-
demiology globally. For example, historically high IMD inci-
dence in the meningitis belt in Africa, led to carriage studies10 
performed by the MenAfriCar consortium in association with 
the introduction of the conjugate polysaccharide A vaccine in 
2010. These surveys identified mean carriage prevalence of 4.5%, 
lower than high IMD incidence, non-African countries, with the 
highest rates amongst 5–14-year-olds in the belt11,12. Risk 
factors in this setting included living in rural communities and the 
dry seasonal climate12.
The human nasopharynx and oropharynx are important sites 
of bacterial colonization supporting a complex and changing 
microbiota. Awareness and knowledge of the complex asso-
ciation of the microbiota is critical to understanding immune 
response and preserving human health as well as its relationship 
to invasive infection. For example, the Human Microbiome Project 
identified Bacteroidetes and Proteobacteria as two of the core 
taxonomic groups within the throat of healthy individuals13. 
In addition, this study found an inverse relationship exists 
between the presence of Bacteriodetes and Proteobacteria, 
which includes the genus Neisseria. Studies of meningococ-
cal carriage prevalence have identified an inverse relationship 
between pathogenic and non-pathogenic Neisseria species1,14,15. 
The studies also indicate that host age, as well as a predomi-
nant species, influenced host susceptibility to colonisation and 
invasion by the pathogenic species, Neisseria meningitidis16,17. 
A relationship between asymptomatic carriage and IMD 
outbreaks has been recognized since pioneering work con-
ducted in the UK in the First World War18, where increased 
meningococcal carriage as a consequence of overcrowding 
and social interactions was found to result in increased rates of 
IMD3,19. There is genotypic and phenotypic diversity amongst 
the meningococci carried in the oropharynx and certain menin-
gococci are inherently more invasive than others. Many genetic 
constituents underlay the phenotypic expression of a meningococ-
cus; for example, the function of capsular expression and other 
virulence factors associated with particular genetic lineages, can 
be defined by multilocus sequence typing (MLST) as a clonal 
complex (cc)12,20–22. In response to an increase in IMD with asso-
ciated high mortality due to a serogroup C, hyperinvasive clonal 
complex ST-11 (C:cc11) the capsular group C meningococcal 
conjugate vaccine (MCC) was introduced into the UK immuni-
sation schedule in November 1999, with a catch up campaign 
for all <18 year olds23. Three large multi-centre carriage surveys 
conducted through the UK Meningococcal Carriage (UKMenCar) 
consortium, UKMenCar1-3, were carried out in 1999, 2000, 
and 2001. These surveys assessed oropharyngeal carriage of 
meningococci and collected risk factor data in over 45,000 
adolescents in the UK; and demonstrated that the population 
immunity induced by the MCC vaccine programme was due 
to the reduction in carriage of the specific hypervirulent strain 
C:cc1124,25.
In the UK, the greatest burden of endemic IMD has been due to 
serogroup B since the 1980s26. Unlike the hyperendemic peri-
ods, which usually represent a clonal expansion of a novel 
strain, endemic disease is caused by multiple different genetic 
lineages of meningococci, which are influenced by secular 
changes22. There has been a progressive fall in overall sero-
group B IMD in the UK since 2000–2001, when in England 
1614/2343 (69%) cases were due to serogroup B compared with 
418/724 (58%) in 2014–2015, predominantly affecting infants 
and children under five26,27. The reasons for this decline in sero-
group B IMD were unclear, in the absence of any national vac-
cination programme targeting capsular group B meningococci. 
Given the changing epidemiology since 1999, this UKMenCar4 
study was performed in 2014–2015 to undertake a structured inves-
tigation of the difference in adolescent meningococcal carriage 
between periods of high (1999–2001) and low (2014–2015) IMD 
incidence using both the phenotypic and genotypic information.
Protocol
Study aims
The aims of the UKMenCar4 study were to: i) characterise a 
representative collection of meningococcal carriage isolates 
from UK adolescents during a period of low IMD incidence; 
ii) identify risk factors associated with meningococcal carriage; 
and iii) to study the relationship between meningococcal carriage 
and disease during periods of high and low IMD incidence.
Study objectives
The specific objective was to characterise the Neisseria spe-
cies obtained as part of the UKMenCar4 study, which sampled 
21,873 adolescents aged 15–19 years attending educational 
establishments in eleven sampling sites around the UK between 
September 2014 and March 2015. These isolates were 
characterized phenotypically and genotypically in order to:
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(i)    identify the Neisseria species present, determining car-
riage rates for N. meningitidis (the meningococcus) 
and other Neisseria species;
(ii)    establish the meningococcal lineages present using 
whole genome sequence data;
(iii)    quantify the meningococcal capsule type prevalence 
and rates of expression;
(iv)    make the data publicly-available via the https://pubmlst.
org/neisseria/ website28.
Study design
The UKMenCar4 study was a cross-sectional survey of menin-
gococcal carriage conducted from September 2014 to March 
2015. Sample collection was funded by the Wellcome Trust 
(087622/Z/08/Z) and a Wellcome Trust Institutional Strategic 
Support Fund and molecular characterization of isolates was 
funded by the UK Department of Health and National Insti-
tute for Health Research (NIHR) Policy Research Programme 
(PR-ST-0915-10015). This study used the same approach and 
sampling methodology as UKMenCar1-3 studies, conducted 
from 1999–2001, in order to ensure comparability20,24,25. Previous 
carriage studies conducted during UKMenCar1-3 had estimated 
carriage in the 15–19-year-old age group at 16.7–18.7%25. A 
sample size of 18,000 participants was calculated to provide 
equivalent numbers of meningococci to UKMenCar1-3 studies, 
assuming a carriage prevalence of 17%25. It was anticipated 
that around 3000 meningococcal isolates would be collected, 
allowing the prevalence of rare strains to be determined with 
good precision, e.g. variants with 1% prevalence, 95% con-
fidence interval 0.85% to 1.15%. Achieving a very large 
unbiased cohort size required a multi-centre design, involv-
ing centres which had a proven recruitment track record. The 
sites were chosen to provide broad geographical distribu-
tion throughout the United Kingdom and encompassing a wide 
range of demographics. Schools and colleges were approached 
directly and asked if they would be willing for students in their 
institution to take part and pre-recruitment numbers were 
estimated, and details regarding the study were made available 
on the school/college website and distributed via newsletter where 
available. To ensure adequate enrolment two additional centres 
were recruited through the clinical trials network. 
Study participants
Adolescents and young adults who were 15–19 years old, 
attending school or college in UK academic years 12 and 13 
or equivalent, were invited for oropharyngeal swab collection 
and completion of a risk factor questionnaire (Extended data, 
file 1)29 following circulation of study information prior to 
school visits by study staff (Figure 1). Students were recruited 
to take part through local schools/colleges in 11 sampling 
centres: Bristol (West England); Cardiff (South Wales); 
Glasgow (Scotland); London; Maidstone (South-East England); 
Manchester; Stockport; Wigan; and Preston (North-West England); 
Oxford (South-Central England); and Plymouth (South-West 
England) (Figure 2). The full information sheet (Extended data, 
file 2)29 was provided in advance of the study for parents to 
discuss with their children and provided the information 
required for informed consent. Adolescents in many schools/
colleges acted as ‘School Ambassadors’, assisting in practi-
cal aspects of the study. The study was approved under the NHS 
Research Ethics Committee reference 14/SC/1163 (Integrated 
Research Approval System 154609).
Sample collection
Written, informed consent was obtained by all study participants. 
After informed consent, individual students were sampled with 
an oropharyngeal swab, inserted past the uvula and sweeping 
the back of the throat. The swab was either inoculated directly 
onto a selective growth media plate (GC agar base containing 
VCAT (vancomycin, colistin, amphotericin and trimethoprim) 
and incubated within 4 hours) or placed directly into STGG 
(skim milk, tryptone, glucose, glycerol) broth for transport to 
a local laboratory for plating (within 4–6 hours). If swabs col-
lected into STGG broth could not be plated in the labora-
tory within 4 hours, they were frozen at -80°C, then thawed 
and cultured as soon as laboratory capacity allowed. Students 
completed a questionnaire including demographic information 
and risk factors for meningococcal carriage. All swabs, plates 
and/or tubes were labelled with a pre-printed unique partici-
pant accession number and cross-referenced to the questionnaire 
and consent form. 
Microbiological culture
After incubation at 37°C, 5% CO2 for 16–24 hours, a representative 
colony of putative Neisseria was sub-cultured onto non-selective 
Columbia blood agar (CBA) plates to obtain a pure, fresh culture 
for further characterisation. Following incubation at 37°C, 5% 
CO2 for a further 16–24 hours, pure sub-cultured colony growth 
was characterised by Gram stain and oxidase reaction. Gram 
negative, oxidase positive diplococci were stored in duplicate 
at -80°C in brain heart infusion and 20% glycerol at the 
processing site or sent to the University of Oxford, UK. A sam-
ple of each recovered putative Neisseria isolate was sent to 
the Public Health England Meningococcal Reference Unit 
(PHE-MRU) in Manchester, UK.
Phenotypic characterization and DNA extraction
At the PHE-MRU, isolates were revived and phenotypically 
characterised for capsular types B, C, W, and Y using stand-
ard serological techniques30. DNA extraction was performed 
using the DNA extraction using the Qiagen DNeasy Blood and 
Tissue Kit (Qiagen, Crawley, UK). A single colony archived 
culture was used to avoid selection of unrepresentative phase 
variants. Purified DNA was quantified and sent to the Oxford 
Genomics Centre (OGC, Wellcome Trust Centre for Human 
Genetics, University of Oxford, UK) for whole genome 
sequencing using the Illumina HiSeq platform.
Whole-genome sequencing and genomic analysis
Short-read sequence data were assembled using Velvet (ver-
sion 1.2.10) with VelvetOptimiser (version 2.2.4) assembly 
package with an established pipeline31. The assembled high-
quality draft genomes were uploaded onto the pubMLST.org 
Neisseria database, which includes the Meningococcal Research 
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Figure 1. Summary overview of the UKMenCar4 study protocol. A cross-sectional survey of meningococcal carriage, conducted from 
September 2014 to March 2015.
Foundation Meningococcal Genome Library (MRF-MGL) 
amongst other meningococcal collections26. Corresponding 
FASTQ files are available from the European Nucleotide Archive 
(study reference PRJEB14319). Each genome was annotated 
using Neisseria locus tag identifiers for >2,400 individual loci, 
including loci belonging to the MLST22, ribosomal MLST32, core 
genome MLST31, capsular genogroup33, and Bexsero® 
Antigen Sequence Typing (BAST)34 schemes. Using a gene-
by-gene analysis approach, isolates that belonged to the genus 
Neisseria and were determined and speciated; each isolate was 
then characterised by sequence type (ST), cc, genetic lineage, 
capsular genogroup, and BAST (protein-based vaccine Bexsero® 
variants) profile.
Data analysis
Data from the UKMenCar4 survey (2014/15) was analysed 
alongside results from UKMenCar1-3 surveys (1999, 2000, and 
2001) for comparison. The UKMenCar4 dataset was prepared by 
reconciling the WGS data with participant questionnaires. 
Samples were excluded if essential questionnaire data were incom-
plete, or if valid consent was missing. All data and statistical 
analyses were performed using Intercooled Stata (version 14)35. 
Initially, individual level risk factors for meningococcal carriage 
will be analysed in single-variable models by using logistic 
regression. A multi-level modelling approach will then be 
used with levels defined as: level 1 individuals, level 2 school, 
and level 3 centre. Univariable analyses will identify risk 
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Figure 2. UKMenCar4 study centres, representing England, Scotland and Wales. Sampling the ethnic diversity of UK cities through 
comprehensive schools, independent schools, and voluntary aided schools, sixth form colleges and technical colleges, mixed and single 
sex schools, day schools and others with boarding facilities, located in areas with different income bands.
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factors at each level with p<0.2, for inclusion in a multilevel 
logistic regression model for a multivariable analysis. We 
will also compare findings between (a) subjects carrying any 
meningococcus, (b) those carrying a meningococcus associ-
ated with invasive disease and (c) those who are not carry-
ing a meningococcus, to allow any specific risk factors for 
disease associated meningococcal carriage to be identified. The 
meningococcal population distribution is described using point 
prevalence for each serogroup with 95% confidence intervals 
and case-carrier ratios for different strains will be calculated 
to look for relative virulence between 1999 and 2014 in the 
carrier population according to circulating disease types. The 
meningococcal genomes and associated risk factor data will be 
publicly-available on https://pubMLST.org/neisseria on final 
acceptance and publication of results.
Data storage and dissemination
Each participant was given a single, unique study number, 
on pre-printed labels, to reduce errors and to facilitate data 
linkage and samples. The name of participants and correspond-
ing study number are kept on a separate and secure database. 
Centres used their preferred method of data capture – paper 
questionnaires or electronic capture. Data was double entered, 
verified, and stored at the site where collected prior to incor-
poration into a central database. Subject associated data 
is stored securely at the study site and only accessible by 
authorised study personnel.
An annual progress report and an end of study final report 
were produced and participating schools informed. Study data, 
isolate characterization, and risk data analysis results will be 
published in peer reviewed scientific journals and provided in 
conference presentations. The collected information will also 
be publically accessible via PubMLST.org in the Neisseria 
database using the project name “UKMenCar4”.
Equality and diversity
Survey sites included comprehensive, independent, and voluntary- 
aided schools, sixth form and technical colleges, mixed- and 
single-sex schools, day schools and others with boarding 
facilities, and located in areas with different income bands. Par-
ticipation was voluntary and those willing to take part were 
random, with the expectation that the cohort was a representa-
tive sample of the communities from which they were obtained, 
with diversity of gender, ethnic, social, educational, and income 
status. 
Patient and public involvement in research
Throughout the UKMenCar4 study, the management group 
engaged with charities (Meningitis Research Foundation and 
Meningitis Now), patient groups (individuals affected by IMD 
and their carers), and prospective participants, who were involved 
in discussions of the study motivation and design. Adolescents 
aged 15–19 years piloted information sheets and question-
naires with their feedback incorporated, including the addition 
of a shorter summary information sheet. ‘School Ambassadors’ 
were involved in ensuring the smooth running of the study 
on site as well as workshops, laboratory visits, and feedback 
sessions. Working alongside charities, public awareness infor-
mation about meningitis was provided including presentations at 
school assemblies and information cards listing meningitis symp-
toms and advice. During the collection of UKMenCar4 samples, a 
three-session course was piloted with a group of 10 year 12 
students. The course comprised:
(i)    a one-hour lecture: ‘At the back of your throat: menin-
gococcal disease and adolescents’, which described the 
basic biology of the meningococcus and the importance 
of transmission and population immunity in prevention of 
meningococcal disease by immunisation;
(ii)    a one-hour computer practical session: ‘How to be a 
genome detective’, in which the students were able to 
use the web-based tools in the MRF-MGL to inves-
tigate the epidemiology of meningococcal disease in 
the UK;
(iii)    a one-hour tutorial on the implementation of menin-
gococcal vaccines. Working in groups of three with a 
tutor, students were provided with various documents 
in advance and were asked to argue from the following 
perspectives: a patient’s parent; a paediatrician; a gov-
ernment official; a vaccine manufacturer. The tutorials 
explored the basis of decisions on immunisation and the 
different conclusions that different individuals might 
make from the same information.
Discussion
Humans are the sole known reservoir for the meningococcus 
and, as such, carriage surveys can provide information about the 
human reservoir and transmission dynamics that have impli-
cations for disease epidemiology. Studying the physiologi-
cal circumstances that promote bacterial invasion rather than 
colonization is difficult as human challenge models are not 
appropriate, but both laboratory36 and mouse37,38 models have 
been developed to address these research questions in vitro. 
Despite this, real life population dynamics are relatively easy to 
measure and monitor through large carriage surveys, though to 
obtain a sample representative of the whole population, studies 
need to be of sufficient magnitude and well-resourced.
Information collected in the UKMenCar1-3 studies demonstrated 
that the MCC vaccine induced population immunity by spe-
cifically reducing carriage of C:cc11, and that the high rates of 
transmission in this age group was a consequence of social 
behaviour, especially smoking, kissing, and attendance at pubs 
and clubs6. In 2014, the UKMenCar consortium was recon-
vened in order to conduct a fourth multi-centre carriage survey 
(UKMenCar4), aiming to provide a large-scale survey of 
meningococcal carriage at a time of low IMD incidence. The 
UKMenCar4 study provides an extensive resource for address-
ing meningococcal epidemiology. Understanding the transmission 
dynamics and changes in carriage over time, will help to explain 
the decline in IMD in the UK from 1999–2019. Characterisation 
of the Neisseria species from this study will provide a definitive 
molecular description of the prevalence and types of meningococci 
carried by UK adolescents in 2014/15. In this study an emphasis 
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was placed on maintaining consistency of sampling and anal-
ysis. Therefore, UKMenCar4 methodology was conducted 
as with previous UKMenCar studies to ensure longitudinal 
comparability. Meningococcal carriage was defined by the 
presence of at least one colony of typical Neisseria species 
morphology on an isolation plate, with reliance on microbio-
logical identification. Further biochemical tests were used to 
confirm the Gram negative, oxidase positive diplococci and WGS 
to determine Neisseria species.
Conventional microbiological approaches to identifying 
the oropharyngeal microbiota has revealed Neisseria to be 
abundant39,40. Standardized collection and laboratory identifica-
tion methods that are robust, scalable, and cost-effective for large 
studies contribute to the overall interpretation and understanding 
of Neisseria epidemiology and its diversity. The UKMenCar4 
study aimed to collect, identify, and genome sequence all 
recovered Neisseria species using methods that allowed com-
parison with the UKMenCar 1-3 surveys. Literature describing 
the methods of sampling, identifying, and measuring menin-
gococcal carriage is abundant; however, at the time of writing 
there was no universally agreed method for carriage studies 
within the academic community, with choice of protocol based 
on specific study questions and aims. Following on from the 
UKMenCar1-3 surveys (1999–2001), large carriage studies were 
undertaken by the MenAfriCar consortium prior to the introduc-
tion of the conjugate polysaccharide A vaccine in 2010 for use 
in the African meningitis belt. Oropharyngeal as opposed to 
nasopharyngeal swabbing was performed in 19 of 20 car-
riage surveys, largely swabbing the posterior pharyngeal wall11. 
Comparison of swabbing sites between the posterior pharynx 
behind the uvula and the posterior pharynx behind the uvula 
and one tonsil, in a direct comparison in Mali, identified that 
carriage where only one site is swabbed may underestimate 
carriage rates41. Alternative samples, such as saliva, are rapid, 
inexpensive, and non-invasive but there are conflicting reports 
on their effectiveness for detecting carriage of Neisseria42–44. The 
UKMenCar surveys sought to optimize the site of swabbing by 
taking a sweep of the posterior pharynx from one tonsil to the 
other.
Once swab samples are obtained, different methods can be 
used for microbiological identification of meningococci. 
Some studies have indicated that PCR methods are an alterna-
tive means of identifying Neisseria from clinical samples and 
have been shown to increase reported cases of IMD45. A large 
multi-centre study in South Australia, studying the impact of 
4CMenB vaccine Bexsero® on adolescent carriage, undertook 
DNA extraction from swabs and real-time PCR screening 
for porA for identification of meningococci and capsular 
group, followed by selective culture of PCR positive swabs. 
This has the benefit of reducing the microbiological time, 
labour and expense of culturing all oropharyngeal swabs and 
increasing sensitivity to low colonization density. However, 
the disadvantages include the inability to identify other Neis-
seria species that lack porA, or other targets (ctrA, siaD), 
such as Neisseria lactamica, or the impact of phase varia-
tion on capsular expression11,46. Both these variables contribute 
to the understanding of the oropharyngeal microbiota and the 
complex interactions and relationships between the different 
Neisseria species that occupy this niche at different ages17, 
with implications for carriage and, therefore, disease due 
to N. meningitidis. A human challenge model of N. lactam-
ica inoculation demonstrated inhibition of N. meningitidis 
colonization16, with potential implications for prevention of IMD, 
though the nature of the intra-species relationships within the 
microbiota remain unclear. Comprehensive studies of the inter-
actions within the oropharyngeal microbiota will increase our 
ability to define risk factors that predispose to carriage and progres-
sion to invasive disease, and develop preventative strategies.
Through WGS analysis of carriage isolates, it is possible to 
determine the antigenic variation of protein antigens present in 
the protein-based vaccines. Hence, the UKMenCar4 study also 
serves as a baseline to analyse further changes in meningococcal 
carriage in the UK after the introduction of 4CMenB vaccine 
into the infant immunization schedule in September 2015. 
Lessons learned from UKMenCar1-4 methodology have been 
important for the efficient design of trials in South Australia24 
and the UK to evaluate the effect of protein-based vaccines on 
meningococcal carriage, especially pathogenic meningococci 
and genogroup B isolates. Such studies can only be powered 
adequately with knowledge of the background prevalence of 
carriage of different types of meningococci, information provided 
by UKMenCar4.
Neisseria are a highly abundant component of the human pha-
ryngeal microbiota and it remains a challenge to understand 
how carried populations contribute to human health and what 
impact carriage has on colonization and prevention of disease 
caused by the hyperinvasive meningococcal lineages in the vast 
majority of people. Meningococcal carriage studies have played an 
important role in developing our understanding of the population 
biology, genotypic and phenotypic epidemiology, as well as the risk 
factors and pathogenesis of IMD. Given the epidemiology of IMD 
is dynamic, through secular changes47 or vaccine interventions25, 
ongoing surveillance of both carriage and disease is crucial for this 




No underlying data are associated with this article.
Extended data
Figshare: UKMenCar4 survey protocol forms. https://doi.
org/10.6084/m9.figshare.8952986.v129.
This project contains the following extended data:
•    extended_data_dile_1.pdf. (Study Questionnaire, used 
to obtain information from study participants regarding 
social demographics and risk factors known to be 
associated with carriage of the meningococcus.)
•    extended_data_file_2.pdf. (Study information sheet describ-
ing the survey and the type of studies the data will be 
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supporting. The sheet was given to students prior to their 
enrolment, to provide ample time to consider the infor-
mation, and the opportunity to question the Investigator, 
their GP or other independent parties to decide whether 
they will participate in the study. Sections highlighted in 
yellow were adapted to reflect the details of the individual 
Centres.)
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
Extended data file 1. Study Questionnaire. Form used to obtain 
information from study participants regarding social demograph-
ics and risk factors known to be associated with carriage of 
the meningococcus.
Extended data file 2. Study Information Sheet. An informa-
tion sheet describing the survey and the type of studies the data 
will be supporting. The sheet was given to students prior to 
their enrolment, to provide ample time to consider the informa-
tion, and the opportunity to question the Investigator, their GP 
or other independent parties to decide whether they will partici-
pate in the study. Sections highlighted in yellow were adapted to 
reflect the details of the individual Centres.
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